Replaces Cognizant Corporation
WESTPORT, Conn., June 24 /PRNewswire/ -- IMS HEALTH (NYSE: RX) announced
today that Standard & Poor's Financial Information Services has placed IMS
HEALTH in the S&P 500 Index, effective after the close of trading on June 30,
1998. IMS HEALTH is a spin-off of Cognizant Corporation (NYSE: CZT).
"The S&P 500 Index listing gives IMS HEALTH broad exposure to investors
who want to participate in the dynamic, growing healthcare information
industry," said Robert E. Weissman, Chairman and CEO of IMS HEALTH.
IMS HEALTH is the world's leading provider of information solutions to the
pharmaceutical and healthcare industries. With more than $1 billion in 1997
revenue, IMS HEALTH operates in over 90 countries. IMS HEALTH is the largest
pharmaceutical manufacturer information partner, with over 40 years'
experience in the industry. Key products and services integral to customer
day-to-day operations include: market research for prescription and
over-the-counter pharmaceutical products; sales management information to
optimize sales force productivity; technology enabled selling solutions for
sales and marketing decision-making; and technology systems and information
services that support managed care organizations.
Additional information is available at http://www.cognizantcorp.com or
http://www.imshealth.com.
SOURCE Cognizant Corporation
 back to top
Related links:
http://www.imshealth.com
Company News On-Call: http://www.prnewswire.com or
fax, 800-758-5804, ext. 115785
CONTACT:
Joseph C. Allen of Cognizant Corporation,
203-222-4235
|
